Effect of weight loss on proteinuria in adults with type 2 diabetes: A real-world study

被引:2
|
作者
Ren, Wenqian [1 ]
Gong, Yujia [1 ]
Zhen, Qin [1 ]
Gu, Liping [1 ]
Yang, Jiaying [1 ]
Kang, Mei [2 ]
Zhang, Aifang [1 ]
Shen, Tingting [1 ]
Wang, Yufan [1 ]
Liu, Fang [1 ,3 ]
Li, Na [1 ,3 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Dept Endocrinol & Metab, Shanghai 200080, Peoples R China
[2] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Clin Med Res Ctr, Sch Med, Shanghai 200080, Peoples R China
[3] 100 Haining Rd, Shanghai 200080, Peoples R China
基金
中国国家自然科学基金;
关键词
Body weight; Proteinuria; Regression; Type; 2; diabetes; CHRONIC KIDNEY-DISEASE; BODY-MASS INDEX; RISK-FACTORS; OBESITY; PREVALENCE; MANAGEMENT;
D O I
10.1016/j.diabres.2023.111021
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: To assess the impact of weight loss on proteinuria in patients with type 2 diabetes (T2DM) in real-world settings. Methods: A total of 1054 participants were categorized based on weight change from baseline to one-year followup: weight gain (>= 3%), stable weight, or weight loss (>= 3%). Proteinuria outcomes were defined as urinary albumin/creatinine ratio (UACR) progression (>= 30 % increase), UACR regression (>= 30 % reduction), or UACR stable. Ordered logistic regression analysis evaluated the relationship between weight loss and UACR regression. Results: Of the 1054 participants, 44.5 % were overweight, and 24.1 % were obese. Patients with obesity were at higher risk of developing proteinuria (OR, 1.783; 95 %CI, 1.195 to 2.659). Weight loss was associated with an 83.3 % increase in UACR regression compared to weight gain (OR, 1.833; 95 % CI, 1.262 to 2.663; P = 0.001). This association remained consistent across most subgroups and stronger in males (P for interaction = 0.023), with a 6 % UACR regression for every 1 kg weight loss (OR, 1.06; 95 % CI, 1.02 to 1.10; P = 0.003). Conclusions: Our real-world study reveals that weight reduction is associated with UACR regression in patients with T2DM, regardless of the approach used for weight management, and the association was much stronger in males.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Glycaemic and weight-loss outcomes of graded doses of canagliflozin in type 2 diabetes - a real-world study
    Dutta, Deep
    Sharma, Meha
    Dhall, Anil
    Aggarwal, Sameer
    Khandelwal, Deepak
    CLINICAL DIABETOLOGY, 2020, 9 (06): : 442 - 453
  • [2] Real-world weight loss with diabetes medications: But is it actually real?
    Elmes, Abigail T.
    Jarrett, Jennie B.
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2022, 62 (01) : 27 - 27
  • [3] Real-world continuous glucose monitoring in adults with type 1 and type 2 diabetes
    Sarri, Grammati
    Zabotka, Luke
    Freitag, Andreas
    Claire, Ravinder
    Wangge, Grace
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 432 - 433
  • [4] Weight Management in Patients with Type 2 Diabetes: a Multidisciplinary Real-world Approach
    Hamdy, Osama
    Ashrafzadeh, Sahar
    Mottalib, Adham
    CURRENT DIABETES REPORTS, 2018, 18 (09)
  • [5] Weight Management in Patients with Type 2 Diabetes: a Multidisciplinary Real-world Approach
    Osama Hamdy
    Sahar Ashrafzadeh
    Adham Mottalib
    Current Diabetes Reports, 2018, 18
  • [6] Glycemic and weight control in people with type 2 diabetes: A real-world observational study in primary care
    Orozco-Beltran, D.
    Mata-Cases, M.
    Artola-Menendez, S.
    Alvarez-Guisasola, F.
    Cebrian-Cuenca, A. M.
    Perez, A.
    PRIMARY CARE DIABETES, 2025, 19 (01) : 7 - 14
  • [7] REAL-world evidence of risk factors and comorbidities in YOUNG Indian adults with type 2 diabetes mellitus: A REAL YOUNG (diabetes) study
    Saboo, Banshi
    Agarwal, Sanjay
    Gupta, Sunil
    Makkar, Brij
    Panneerselvam, A.
    Sahoo, Abhay Kumar
    Ramchandani, G. D.
    Das, Sambit
    Erande, Suhas
    Kadam, Yogesh
    Abhyankar, Mahesh, V
    Revankar, Santosh
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2021, 10 (09) : 3444 - 3452
  • [8] A Real-World Study of the Effectiveness and Safety of Semaglutide for Weight Loss
    Tzoulis, Ploutarchos
    Batavanis, Michael
    Baldeweg, Stephanie
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (05)
  • [9] Real-World Study on the Effect of SGLT2 Inhibitors in Patients with Type 2 Diabetes in China
    Xue, Yaoming
    Shi, Lixin
    Yu, Xuefeng
    Wang, Yangang
    Hong, Tianpei
    Li, Xiaoying
    Ma, Jianhua
    Zhu, Dalong
    Mu, Yiming
    DIABETES, 2024, 73
  • [10] Real-World Weight-Loss Effectiveness of GLP-1 Agonists among Patients with Type 2 Diabetes: A Retrospective Cohort Study
    Luo, Jing
    Shu, Ingrid
    Korytkowski, Mary T.
    Rometo, David A.
    Arnold, Jonathan
    White, Gretchen E.
    DIABETES, 2022, 71